Wijziging van de Geneesmiddelenwet ter implementatie van Richtlijn 2010/84/EU ter verbetering van de publieke gezondheid door het systeem van de geneesmiddelenbewaking van humane geneesmiddelen efficiënter te maken

This amendment updates the national Medicines Act to implement EU Directive 2010/84/EU. The goal is to strengthen the pharmacovigilance system, which is the process of monitoring the safety of medicinal products for human use to protect public health. This change affects pharmaceutical companies and healthcare providers by introducing more efficient monitoring and reporting standards for drug safety.